High Court Denies Petition to Review Patent Product-by-Process Infringement Rule

摘要

On Jan. 11, the U.S. Supreme Court denied a petition for a writ of certiorari in Astellas Pharma Inc. v. Lupin Ltd. (U.S., No. 09-335, review denied 1/11/10), appealing the Federal Circuit's ruling that infringement of a product-by-process patent claim requires a showing of equivalent processes used in making the alleged infringer's product. Abbott Laboratories v. Sandoz Inc., 566 F.3d 1282, 90 USPQ2d 1769 (Fed. Cir. 2009) (78 PTCJ 106, 5/29/09).